Enlivex Therapeutics Ltd. (ENLV)
USD 1.2
(1.69%)
USD 1.2
(1.69%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 2.27 Million | - | - |
| Cost of Revenue | 835 Thousand | 777 Thousand | 546 Thousand | 286 Thousand | 297 Thousand | 121 Thousand |
| Gross Profit | -835 Thousand | -777 Thousand | -546 Thousand | 1.99 Million | -297 Thousand | -121 Thousand |
| Operating Expenses | 29.39 Million | 25.79 Million | 19.28 Million | 9.78 Million | 8.61 Million | 5.29 Million |
| Selling, General and Administrative Expenses | 6.13 Million | 6.7 Million | 6.24 Million | 3.6 Million | 2.75 Million | 937 Thousand |
| Research and Development Expenses | 19.23 Million | 18.69 Million | 12.88 Million | 6.08 Million | 5.72 Million | 4.25 Million |
| Other Expenses | 4.02 Million | 402 Thousand | 167 Thousand | 97 Thousand | 145 Thousand | - |
| Cost and Expenses | 29.39 Million | 25.79 Million | 19.28 Million | 9.78 Million | 8.61 Million | 5.29 Million |
| Operating Income | -29.39 Million | -25.79 Million | -19.28 Million | -9.78 Million | -8.61 Million | -5.29 Million |
| Interest Expense | 14 Thousand | 5.26 Million | 328 Thousand | 6000.00 | 7000.00 | - |
| Income Tax Expense | - | 11.34 Million | -4.82 Million | 2.03 Million | 765 Thousand | 1.05 Million |
| Earnings before Tax | -29.06 Million | -31.06 Million | -14.46 Million | -11.82 Million | -9.38 Million | -4.24 Million |
| Net Income | -29.06 Million | -42.4 Million | -9.64 Million | -13.86 Million | -10.14 Million | -4.24 Million |
| Earnings Per Share Basic | -1.56 | -2.31 | -0.54 | -1.05 | -1.17 | -1.21 |
| Earnings Per Share Diluted | -1.56 | -2.31 | -0.54 | -1.05 | -1.17 | -1.21 |
| Weighted Average Shares Outstanding | 18.57 Million | 18.39 Million | 17.85 Million | 13.16 Million | 8.64 Million | 3.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.57 Million | 18.39 Million | 17.85 Million | 13.16 Million | 8.64 Million | 3.5 Million |
| Gross Margin | - | - | - | 0.87 | - | - |
| EBIT Margin | - | - | - | -3.18 | - | - |
| Profit Margin | - | - | - | -6.09 | - | - |
| EBITDA | -28.21 Million | -25.02 Million | -18.74 Million | -9.49 Million | -9.08 Million | -5.17 Million |
| Earnings Before Tax Margin | - | - | - | -4.30 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 160 Thousand | 188 Thousand | 835 Thousand | 200 Thousand | 214 Thousand | 212 Thousand |
| Gross Profit | -160 Thousand | -188 Thousand | -835 Thousand | -200 Thousand | -214 Thousand | -212 Thousand |
| Operating Expenses | 2.82 Million | 3.76 Million | 24.09 Million | 5.89 Million | 5.62 Million | 6.64 Million |
| Selling, General and Administrative Expenses | 827 Thousand | 905 Thousand | - | 1.43 Million | 1.27 Million | 1.61 Million |
| Research and Development Expenses | 1.99 Million | 2.85 Million | - | 4.45 Million | 4.34 Million | 5.03 Million |
| Other Expenses | - | - | - | - | -335 Thousand | -143 Thousand |
| Cost and Expenses | 2.98 Million | 3.95 Million | 24.92 Million | 6.09 Million | 5.62 Million | 6.64 Million |
| Operating Income | -2.98 Million | -3.95 Million | -24.92 Million | -6.09 Million | -5.62 Million | -6.64 Million |
| Interest Expense | - | - | 14 Thousand | - | - | - |
| Income Tax Expense | - | 144.72 Thousand | - | 156.18 Thousand | 253.58 Thousand | 89.91 Thousand |
| Earnings before Tax | -3.09 Million | -4.14 Million | -29.06 Million | -9.09 Million | -5.96 Million | -6.79 Million |
| Net Income | -3.09 Million | -4.14 Million | -29.06 Million | -9.09 Million | -5.96 Million | -6.79 Million |
| Earnings Per Share Basic | -0.16 | -0.22 | - | -0.49 | -0.32 | -0.37 |
| Earnings Per Share Diluted | -0.16 | -0.22 | - | -0.49 | -0.32 | -0.37 |
| Weighted Average Shares Outstanding | 19.54 Million | 18.72 Million | 18.57 Million | 18.59 Million | 18.59 Million | 18.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 19.54 Million | 18.72 Million | 18.57 Million | 18.59 Million | 18.59 Million | 18.58 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -2.82 Million | -3.76 Million | - | -5.89 Million | -5.41 Million | -6.43 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
NSIL
OMAGQ
AAMAF
601609
600887
GOEL